Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

Giving Notice: How Workforce Attrition Impacts Workers’ Comp

Millions of workers are changing occupations, leading to ripple effects for comp.
Summer 2022

State of the States

A roundup of regulatory activity around the country
Summer 2022

Sickness and Society: The Future of Infectious Disease in the Workplace

Strategies for a safer, healthier workface amid COVID-19 and beyond.
Winter 2021/2022

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

DEA to Reschedule Marijuana

While bureaucratic wheels may take time, marijuana will become a Schedule III drug soon.
May 2024

Maximizing Efficiency and Streamlining Claims Management Processes

Healthe’s VP of Clinical Services, Silvia Sacalis, will co-present this educational session at PRIMA 2024.
May 2024

Lot of Methocarbamol Recalled Due to White Particles

Patients taking this muscle relaxant may be impacted by a lot from Eugia US/AuroMedics Pharma.
Apr 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Remdesivir a Potential Treatment for COVID-19?

The FDA allows emergency use in response to positive trials, but more research is needed.
May 2020

Update on Antibody Testing

Testing for COVID-19 antibodies is not a conclusive test for infection.
Apr 2020

FDA Authorizes First COVID-19 Test for At-Home Sample Collection

This is NOT an at-home test. Samples collected at home must be sent to a LabCorp facility.
Apr 2020
1 12 13 14 15 16 25

Whitepapers

lockenvelopephone-handsetmagnifiermenucross-circle